June 29, 2020 / 9:29 PM / 15 days ago

BRIEF-Oncocyte Announces Completion Of Determadx Clinical Validation Study

June 29 (Reuters) - OncoCyte Corp:

* ONCOCYTE ANNOUNCES COMPLETION OF DETERMADX™ CLINICAL VALIDATION STUDY

* ONCOCYTE CORP - FINDINGS DEMONSTRATED THAT PERFORMANCE OF DETERMADX DID NOT MEET PREDETERMINED ENDPOINTS FOR STUDY.

* ONCOCYTE CORP - TO NOW FOCUS RESOURCES ON ACCELERATING DETERMARX AND DETERMAIO

* ONCOCYTE CORP - MADE DECISION TO CEASE FURTHER INVESTMENT IN DETERMADX Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below